SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Medicinska grundvetenskaper) "

Sökning: hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Medicinska grundvetenskaper)

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Blomgren, Klas, 1963-, et al. (författare)
  • Pathological apoptosis in the developing brain
  • 2007
  • Ingår i: Apoptosis. - 1360-8185. ; 12:5, s. 993
  • Forskningsöversikt (refereegranskat)abstract
    • More than half of the initially-formed neurons are deleted in certain brain regions during normal development. This process, whereby cells are discretely removed without interfering with the further development of remaining cells, is called programmed cell death (PCD). The term apoptosis is used to describe certain morphological manifestations of PCD. Many of the effectors of this developmental cell death program are highly expressed in the developing brain, making it more susceptible to accidental activation of the death machinery, e.g. following hypoxia-ischemia or irradiation. Recent evidence suggests, however, that activation and regulation of cell death mechanisms under pathological conditions do not exactly mirror physiological, developmentally regulated PCD. It may be argued that the conditions after e.g. ischemia are not even compatible with the execution of PCD as we know it. Under pathological conditions cells are exposed to various stressors, including energy failure, oxidative stress and unbalanced ion fluxes. This results in parallel triggering and potential overshooting of several different cell death pathways, which then interact with one another and result in complex patterns of biochemical manifestations and cellular morphological features. These types of cell death are here called "pathological apoptosis," where classical hallmarks of PCD, like pyknosis, nuclear condensation and caspase-3 activation, are combined with non-PCD features of cell death. Here we review our current knowledge of the mechanisms involved, with special focus on the potential for therapeutic intervention tailored to the needs of the developing brain.
  •  
2.
  •  
3.
  • Zhu, Changlian, 1964-, et al. (författare)
  • X chromosome-linked inhibitor of apoptosis protein reduces oxidative stress after cerebral irradiation or hypoxia-ischemia through up-regulation of mitochondrial antioxidants.
  • 2007
  • Ingår i: The European journal of neuroscience. - 1460-9568. ; 26:12, s. 3402
  • Tidskriftsartikel (refereegranskat)abstract
    • We demonstrate that X chromosome-linked inhibitor of apoptosis protein (XIAP) counteracts oxidative stress in two essentially different disease-related models of brain injury, hypoxia-ischemia and irradiation, as judged by lower expression of nitrotyrosine (5-fold) and 4-hydroxy-2-nonenal (10-fold) in XIAP-overexpressing compared with wild-type mice. XIAP overexpression induced up-regulation of at least three antioxidants residing in mitochondria, superoxide dismutase 2, thioredoxin 2 and lysine oxoglutarate reductase. Cytochrome c release from mitochondria was reduced in XIAP-overexpressing mice. Hence, in addition to blocking caspases, XIAP can regulate reactive oxygen species in the brain, at least partly through up-regulation of mitochondrial antioxidants. XIAP-induced prevention of oxidative stress was not secondary to tissue protection because although XIAP overexpression provides tissue protection after hypoxia-ischemia, it does not prevent tissue loss after irradiation. This is a previously unknown role of XIAP and may provide the basis for development of novel protective strategies for both acute and chronic neurodegenerative diseases, where oxidative stress is an integral component of the injury mechanisms involved.
  •  
4.
  • Abbas, Abdul-Karim, 1959-, et al. (författare)
  • Long-term potentiation and insult conditioning in hippocampal slices from young rats: a role for protein synthesis under chemical stress?
  • 2010
  • Ingår i: The 10th Biennial Meeting of the Asia-Pacific Society for Neurochemistry (APSN), October 17-20, 2010, Phuket, Thailand.
  • Konferensbidrag (övrigt vetenskapligt)abstract
    • We have previously demonstrated that in young rats (12-20-day-old) a sustained long-term potentiation (LTP) can still be induced under conditions of protein synthesis inhibition. It was therefore suggested that sufficient and necessary proteins were already available at the induction time to accomplish LTP maintenance for several hours. Against this background, we have questioned whether hippocampal slices subjected to certain insult conditions might be more sensitive to protein synthesis inhibitors. High K+ concentration has previously been reported to cause an amnesic effect in vivo as well as increasing protein turnover in vitro. We have here employed a K+ insult model under conditions when protein synthesis was inhibited. Recordings were obtained from hippocampal slices for up to 9 h, with or without a cocktail of protein synthesis inhibitors, containing cycloheximide (60 µM) and anisomycin (25 µM). High potassium (50 mM) was transiently applied (5-15 min) shortly after inducing LTP in one of two separate pathways stimulated alternatively. Additionally, an NMDA-receptor antagonist AP5 was supplied after LTP induction to minimize effects related to depolarization-induced glutamate release. Following elimination of all responses for about 30 min, both test and control responses partly recovered. The degree of remaining LTP, defined as test/control ratio, was reduced in both groups of slices (NMDA-independent depotentiation) but was significantly smaller in the drug-treated ones. We are also running an insult model based on oxidative stress, applying hydrogen peroxide (4-5 mM) before or after LTP induction; however, the results are still insufficient for a final conclusion. The potency of cycloheximide, anisomycin or cocktail of the drugs was verified by measurement of incorporation of [3H]-leucine into trichloracetic acid (TCA) precipitable macromolecules. Cycloheximide, anisomycin or cocktail, at concentrations used here caused 95%, 97% and 95% blocking effect, respectively. Our data confirm the idea that sufficient and necessary constitutive proteins are available in the young hippocampus to maintain LTP under conditions of protein synthesis inhibition. They also reveal that LTP in slices subjected to certain insult conditions early after the induction is sensitive to protein synthesis inhibition, probably due to increase in constitutive proteins turnover.
  •  
5.
  • Deshpande, J, et al. (författare)
  • Ultrastructural changes in the hippocampal CA1 region following transient cerebral ischemia: evidence against programmed cell death.
  • 1992
  • Ingår i: Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale. - 0014-4819. ; 88:1, s. 91
  • Tidskriftsartikel (refereegranskat)abstract
    • The ultrastructural changes in the pyramidal neurons of the CA1 region of the hippocampus were studied 6 h, 24 h, 48 h, and 72 h following a transient 10 min period of cerebral ischemia induced by common carotid occlusion combined with hypotension. The pyramidal neurons showed delayed neuronal death (DND), i.e. at 24 h and 48 h postischemia few structural alterations were noted in the light microscope, while at 72 h extensive neuronal degeneration was apparent. The most prominent early ultrastructural changes were polysome disaggregation, and the appearance of electron-dense fluffy dark material associated with tubular saccules. Mitochondria and nuclear elements appeared intact until frank neuronal degeneration. The dark material accumulated with extended periods of recirculation in soma and in the main trunks of proximal dendrites, often beneath the plasma membrane, less frequently in the distal dendrites and seldom in spines. Protein synthesis inhibitors (anisomycin, cycloheximide) and an RNA synthesis inhibitor (actinomycin D), administered by intrahippocampal injections or subcutaneously, did not mitigate neuronal damage. Therefore, DND is probably not apoptosis or a form of programmed cell death. We propose that the dark material accumulating in the postischemic period represents protein complexes, possibly aggregates of proteins or internalized plasma membrane fragments, which may disrupt vital cellular structure and functions, leading to cell death.
  •  
6.
  •  
7.
  • Zetterberg, Madeleine, et al. (författare)
  • Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y polymorphism in Alzheimer's disease.
  • 2010
  • Ingår i: Molecular neurodegeneration. - 1750-1326. ; 5
  • Tidskriftsartikel (refereegranskat)abstract
    • Alzheimer's disease (AD) is characterized by protein aggregates, i.e. senile plaques and neurofibrillary tangles. The ubiquitin-proteasome system has been proposed a role in proteolytic removal of these protein aggregates. Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) is a de-ubiquitinating enzyme with important functions in recycling of ubiquitin. The S18Y polymorphism of the UCHL1 gene confers protection against Parkinson's disease. In this study, the genotype and allele frequencies of the UCHL1 S18Y polymorphism were investigated in 452 AD patients and 234 control subjects, recruited from four memory clinics in Sweden. Using a binary logistic regression model including UCHL1 allele A and APOE epsilon 4 allele positivity, age and sex as covariates with AD diagnosis as dependent variable, an adjusted OR of 0.82 (95% CI 0.55-1.24, P = 0.35) was obtained for a positive UCHL1 allele A carrier status. The present study thus do not support a protective effect of the UCHL1 S18Y polymorphism against AD.
8.
  • Wold, Agnes E, 1955-, et al. (författare)
  • Breast feeding and the intestinal microflora of the infant--implications for protection against infectious diseases.
  • 2000
  • Ingår i: Advances in experimental medicine and biology. - 0065-2598. ; 478, s. 77-93
  • Forskningsöversikt (refereegranskat)abstract
    • Human breast milk contains an array of factors with anti-infectious potential, such as immunoglobulins (especially secretory IgA), oligosaccharides and glycoproteins with anti-adhesive capacity, and cytokines. Breast-feeding is associated with protection from the following infections or infection-related conditions: gastroenteritis, upper and lower respiratory tract infection, acute otitis media, urinary tract infection, neonatal septicaemia and necrotizing enterocolitis. Some of the protective effects may derive from an altered mucosal colonization pattern in the breast-fed infant. In other instances breast-fed infants develop less symptoms to the same microbe which causes disease in the bottle-fed infant. An example of an altered colonization pattern is that breast-fed infants have less P-fimbriated, but more type 1-fimbriated E. coli. This may protect against urinary tract infection in the breast-fed infant since P. fimbriae are the major virulence factor for urinary tract infection. An example of changed consequences of the same microbial colonization is that secretory IgA in the breast-milk protects very efficiently from translocation of intestinal bacteria across the gut mucosa by coating intestinal bacteria and blocking their interaction with the epithelium. This mechanism may protect the infant from septicaemia of gut origin and, possibly, necrotizing enterocolitis. Breast-milk is also highly anti-inflammatogenic and contains hormone like factors which counteract diarrhea. Thus, breast-fed infants may be colonized by recognized diarrheal pathogens and still remain healthy. Due to a less virulent intestinal microflora and decreased translocation breast-fed infants will obtain less stimuli for the gut immune system, resulting, in e.g., lower salivary IgA antibody titres.
  •  
9.
  • Abbas, Abdul-Karim, 1959-, et al. (författare)
  • Pharmacological characteristics of protein synthesis inhibitors by radioactive leucine incorporation in rat hippocampal slices: experimental evidence and pre-clinical implications
  • 2011
  • Ingår i: The 23rd Biennial Meeting of the International Society for Neurochemistry (ISN), August 28-September 1 2011, Athens, Greece.
  • Konferensbidrag (övrigt vetenskapligt)abstract
    • Protein synthesis inhibitors (PSIs) constitute a major tool to validate the hypothesis of protein synthesis-dependent phase of synaptic plasticity and memory consolidation. However, several reports have showed inconsistent findings about the effect of these drugs on behavioral learning and synaptic plasticity. Testing the potencies of these drugs is hence crucial for validating such negative findings and in planning future studies. It is also necessary to examine the dose dependence, onset dynamics and reversibility, and possible effects on basal proteins. Here we used the labeled leucine as marker for the newly synthesized proteins. The fraction of leucine incorporation, following 50 min of pre-incubation, was compared between two groups of slices: a PSI-treated and a control group. Both anisomycin and cycloheximide revealed a dose-dependent but time-independent manner of inhibition reaching over 92% at concentrations well below those used in previous experiments which revealed effects on synaptic plasticity and learning. Surprisingly, washout of a “reversible” inhibitor, anisomycin was not followed by rapid reversibility of the action of the drug, the case that differs with cycloheximide. Interestingly, emetine revealed a time-dependent inhibition of protein synthesis, where levels above 80% needed drug pre-incubation for as long as 90 min. Since the duration of labeling relates to the half-life of the proteins, short-time labeling as used in this study will result in radioactivity incorporation into short-lived proteins and proteins that are synthesized in large quantities. We therefore studied the availability of newly synthesized proteins at 8-10 h following leucine incorporation. The results revealed virtually the same protein content as in slices retrieved for analysis immediately following the labeling period, indicating that the main pool of the newly synthesized proteins is of intracellular long-lived pool. This likely reflects a stable metabolic state of our prepared slices. These findings challenge current idea on the role of de novo protein synthesis in synaptic plasticity as well as brain changes underlying several neurological and psychiatric disorders.
  •  
10.
  • Dinér, Peter, 1976-, et al. (författare)
  • Preparation of 3-Substituted-1-Isopropyl-1H-pyrazolo 3,4-d pyrimidin-4-amines as RET Kinase Inhibitors
  • 2012
  • Ingår i: Journal of Medicinal Chemistry. - 0022-2623. ; 55:10, s. 4872-4876
  • Tidskriftsartikel (refereegranskat)abstract
    • A series of 3-substituted-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-amines have been designed, synthesized, and evaluated as RET protein kinase inhibitors. On the basis of docking results, a small library of pyrazolopyrimidine compounds with an extended hydrophobic side arm was synthesized. The most promising of the compounds (7a) displayed efficient inhibition in vitro and good selectivity when tested on a panel of kinases. Furthermore, 7a inhibited GDNF-induced RET phosphorylation of ERK1/2 in MCF-7 breast cancer cells at concentrations as low as 100 nM.
  •  
Skapa referenser, mejla, bekava och länka
Åtkomst
fritt online (277)
Typ av publikation
tidskriftsartikel (3976)
konferensbidrag (360)
forskningsöversikt (278)
doktorsavhandling (195)
bokkapitel (116)
annan publikation (27)
visa fler...
rapport (17)
licentiatavhandling (15)
bok (13)
samlingsverk (redaktörskap) (10)
recension (6)
patent (1)
visa färre...
Typ av innehåll
refereegranskat (4334)
övrigt vetenskapligt (657)
populärvet., debatt m.m. (22)
Författare/redaktör
Blennow, Kaj, 1958-, (177)
Zetterberg, Henrik, ... (150)
Fu, Michael, 1963-, (111)
Eriksson, Elias, 195 ... (79)
Svennerholm, Ann-Mar ... (77)
Jankowska, Elzbieta, (73)
visa fler...
Gisslén, Magnus, 196 ... (70)
Backhaus, Thomas, 19 ... (70)
Holmgren, Jan, 1944- ... (69)
Wold, Agnes E, 1955- ... (69)
Tobin, Gunnar, 1954- ... (66)
Falsen, Enevold, 193 ... (65)
Engel, Jörgen, 1942- ... (56)
Munthe, Christian, 1 ... (50)
Söderpalm, Bo, 1959- ... (47)
Dickson, Suzanne L., ... (47)
Lötvall, Jan, 1956-, (46)
Ekström, Jörgen, 194 ... (44)
Westberg, Lars, 1973 ... (44)
Blomgren, Klas, 1963 ... (44)
Ashton, Michael, 195 ... (41)
Hagberg, Lars, 1951- ... (40)
Wessberg, Johan, 196 ... (40)
Hellstrand, Kristoff ... (40)
Lindh, Magnus, 1960- ... (40)
Adlerberth, Ingegerd ... (39)
Lycke, Nils Y, 1954- ... (39)
Nilsson, Staffan, 19 ... (38)
Stener-Victorin, Eli ... (38)
Hammar, Ingela, 1964 ... (36)
Hjalmarson, Åke, 193 ... (36)
Bäckhed, Fredrik, 19 ... (36)
Ericson, Mia, 1970-, (35)
Odén, Anders, 1942-, (35)
Stenman, Göran, 1953 ... (35)
Mattsson, Niklas, 19 ... (35)
Hanson, Lars Åke, 19 ... (34)
Ohlsson, Claes, 1965 ... (34)
Egecioglu, Emil, 197 ... (34)
Hansson, Gunnar C., ... (34)
Nilsson, Michael, 19 ... (34)
Dahlgren, Claes, 194 ... (34)
Johansson, Helena, 1 ... (34)
Bergström, Tomas, 19 ... (33)
Billig, Håkan, 1955- ... (33)
Hoebeke, Johan (33)
Lindahl, Anders, 195 ... (32)
Barregård, Lars, 194 ... (32)
Hedner, Thomas, 1949 ... (32)
Pekny, Milos, 1965-, (32)
visa färre...
Lärosäte
Göteborgs universitet (4829)
Chalmers tekniska högskola (390)
Uppsala universitet (246)
Lunds universitet (224)
Umeå universitet (136)
Linköpings universitet (122)
visa fler...
Kungliga Tekniska Högskolan (32)
Stockholms universitet (24)
Örebro universitet (15)
Högskolan i Borås (12)
Högskolan i Skövde (10)
Linnéuniversitetet (8)
Malmö högskola (8)
Karlstads universitet (5)
Mittuniversitetet (4)
Karolinska institutet (4)
Högskolan Dalarna (3)
Mälardalens högskola (3)
Södertörns högskola (2)
Högskolan Väst (2)
Högskolan Kristianstad (2)
Luleå tekniska universitet (2)
Högskolan i Halmstad (2)
Högskolan i Jönköping (2)
Naturvårdsverket (1)
visa färre...
Språk
Engelska (4864)
Svenska (136)
Tyska (4)
Spanska (2)
Danska (1)
Ryska (1)
visa fler...
Italienska (1)
visa färre...
Ämne (HSV)
Medicin och hälsovetenskap (5014)
Naturvetenskap (565)
Samhällsvetenskap (191)
Teknik (136)
Humaniora (64)
Lantbruksvetenskap (36)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy